Literature DB >> 24674619

Pseudoexfoliation and mortality: a population-based 30-year follow-up study.

Rebecka Svensson1, Curt Ekström.   

Abstract

PURPOSE: To study the relationship between pseudoexfoliation (PEX) and all-cause mortality in a population in which PEX is a common finding.
METHODS: Survival analyses were performed in a cohort of 760 residents 65-74 years of age, examined in a population survey in the municipality of Tierp, Sweden, 1984-86. To expand the cohort, participants in other studies in Tierp were enrolled. Additionally, people were recruited by means of glaucoma case records established at the Eye Department in Tierp in 1978-2007. In this way, the cohort comprised 1524 subjects, representing more than 21,100 person-years at risk. Information on deaths was obtained from the local population register.
RESULTS: By the conclusion of the study, in August 2013, 1280 deaths had been reported. Of these cases, 350 were affected by PEX at baseline. No association between PEX and mortality was found (hazard ratio 1.00; 95% confidence interval 0.88-1.14).
CONCLUSION: The results strongly suggest that PEX had no effect on all-cause mortality in the population under study.
© 2014 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  all-cause mortality; epidemiology; exfoliation syndrome; mortality rate; pseudoexfoliation; risk factor; survival

Mesh:

Year:  2014        PMID: 24674619     DOI: 10.1111/aos.12402

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  8 in total

1.  Pseudoexfoliation syndrome: analysis of systemic comorbidities of 325 PEX-positive patients compared with 911 PEX-negative patients.

Authors:  Elizabeth Scharfenberg; Franziska G Rauscher; Petra Meier; Dirk Hasenclever
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-16       Impact factor: 3.117

2.  Genetics, Diagnosis, and Monitoring of Pseudoexfoliation Glaucoma.

Authors:  Niraj Nathan; Rachel W Kuchtey
Journal:  Curr Ophthalmol Rep       Date:  2016-10-11

3.  Exfoliation syndrome: association with systemic diseases-the Maccabi glaucoma study.

Authors:  Tzukit Zehavi-Dorin; Nofar Nahum; Elad Ben-Artsi; Hani Levkovitch-Verbin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-06-25       Impact factor: 3.117

Review 4.  Cataract surgery in patients with pseudoex-foliation syndrome: current updates.

Authors:  Luigi Fontana; Marco Coassin; Alfonso Iovieno; Antonio Moramarco; Luca Cimino
Journal:  Clin Ophthalmol       Date:  2017-07-31

5.  Significant lifespan difference between primary open-angle glaucoma and pseudoexfoliation glaucoma.

Authors:  Jon Klokk Slettedal; Leiv Sandvik; Amund Ringvold
Journal:  Heliyon       Date:  2021-03-13

6.  Comparison of Cardiovascular Risk and Events among Spanish Patients with and without Ocular Pseudoexfoliation.

Authors:  Nora Imaz Aristimuño; Iñaki Rodriguez Agirretxe; Ricardo San Vicente Blanco; Rafael Rotaeche Del Campo; Javier Mendicute Del Barrio
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

7.  Ocular pseudoexfoliation syndrome and life span.

Authors:  Jon Klokk Slettedal; Leiv Sandvik; Amund Ringvold
Journal:  EBioMedicine       Date:  2015-05-30       Impact factor: 8.143

8.  Lifespan reduction due to neoplasia is nullified by pseudoexfoliation syndrome.

Authors:  Jon Klokk Slettedal; Leiv Sandvik; Amund Ringvold
Journal:  Heliyon       Date:  2018-10-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.